The current polls from Electoral-Vote.com
Flaws in Government Tool to ID Noncitizen Voters
Republican Sen. Mike Lee said that he believes there are "at least tens of thousands, probably hundreds of thousands" of noncitizens illegally registered to vote in the U.S., adding that a federal tool used in nearly two dozen states would help identify the number. But the tool has wrongly flagged many as being noncitizens, and there's no evidence of widespread noncitizen voting.
The post Flaws in Government Tool to ID Noncitizen Voters appeared first on FactCheck.org.
Competing Claims on SAVE America Act Disenfranchising Voters
Senate Minority Leader Chuck Schumer has said the SAVE America Act "could disenfranchise over 20 million American citizens," while Republicans dispute that the voter registration and ID bill would block any legitimate voters. Election experts say the bill, which isn't expected to pass, would make it difficult for some unknown number of voters to register and cast a vote.
The post Competing Claims on SAVE America Act Disenfranchising Voters appeared first on FactCheck.org.
On March 17, the Senate began debate on the SAVE America Act, a Republican-backed voter identification and registration bill that passed the House last month. Here, we answer several questions about the legislation, many of them asked by our readers.
The post Q&A on the SAVE America Act appeared first on FactCheck.org.
EPA’s Misleading Claim of $1.3 Trillion in Deregulatory ‘Savings’
Trump administration officials have claimed that they are saving Americans over $1.3 trillion by ending regulation of greenhouse gas emissions from cars and trucks. But the figure does not incorporate any benefits of the emissions standards. By one of the Environmental Protection Agency’s own calculations, getting rid of the standards could cost billions.
The post EPA’s Misleading Claim of $1.3 Trillion in Deregulatory ‘Savings’ appeared first on FactCheck.org.
No Broad Autism Approval for Leucovorin, Despite FDA Commissioner’s Prior Suggestions
The Food and Drug Administration on March 10 changed the approval for a version of the prescription drug leucovorin to include people with a very rare genetic condition. FDA Commissioner Dr. Marty Makary had previously implied that the drug’s new label would cover a much broader group of people with autism, saying that “hundreds of thousands of kids” would benefit.
The post No Broad Autism Approval for Leucovorin, Despite FDA Commissioner’s Prior Suggestions appeared first on FactCheck.org.
